Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital Quality Foundation
With
Prove pharm
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult or pediatric patients diagnosed with acquired methemoglobinemia and receiving treatment with ProvayBlue® (methylene blue 0.5%) as per the treating physician's diagnosis and the acute care facility's standard of care
Those acquired methemoglobinemia patients whose diagnosis is aided by measurement of methemoglobin and whose ongoing treatment is guided by re-measurement of methemoglobin \~1h post-treatment with ProvayBlue® in accordance with the US FDA Label prescribing information
You may not be if
Refusal of consent (in those subjects approached for consent where required by local institutional procedures)
Treatment of methemoglobinemia with another methylene blue product
